Close Cookie Popup
Cookie Preferences
By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our cookie policy.
Strictly Necessary (Always Active)
Cookies required to enable basic website functionality.
Cookies helping us understand how this website performs, how visitors interact with the site, and whether there may be technical issues.
Cookies used to deliver advertising that is more relevant to you and your interests.
Cookies allowing the website to remember choices you make (such as your user name, language, or the region you are in).

Ventures

Invest in breakthrough healthtech solutions that transform patients' lives.

00:00
/
00:00
00:00
/
00:00
Invest in transformative health innovations
Invest in transformative health innovations

We vet over 1500 innovations yearly and identify, build, and invest in 20 to 25 ventures that address crucial, unmet needs in the healthcare sector. Our ventures lead in areas such as personalized medicine, AI diagnostics, and medical devices, all of which show substantial potential for growth, return, and impact.

00:00
/
00:00
00:00
/
00:00
Invest alongside NLC
Invest alongside NLC

As an investor in an NLC venture, you always invest alongside NLC. Our team of 80+ experts offers comprehensive support to our ventures, including regulatory guidance, product development assistance, and clinical trial setup. This extensive, tailored support system de-risks your investment and enhances the likelihood of venture success. Single-company investments start at €25K.

00:00
/
00:00
00:00
/
00:00
Invest with impact
Invest with impact

By investing in one of our ventures, you help bring transformative health solutions to patients in need, directly impacting their lives. NLC is a certified B Corp and supports UN Sustainable Development Goals 3, 9, and 17, our funds are SDFR-9 compliant, which means we adhere to the strictest impact regulations. Investing in NLC ventures can be your pathway to high-impact capital deployment.

Receive the latest investment opportunities that match your interests, directly in your inbox. Stay informed and never miss out.

a highlight from our portfolio

Angiogenesis Analytics

Angiogenesis Analytics

Angiogenesis Analytics is transforming prostate cancer diagnosis by integrating artificial intelligence with advanced ultrasound technology. Our mission is to make the detection of prostate cancer quicker, more affordable, and significantly less invasive than traditional methods. By pioneering the innovative PCAVision technology, we are setting new standards in healthcare.
Visit website
Download documents
PEP Health

PEP Health

PEP Health is revolutionizing how healthcare providers understand and improve patient experiences by leveraging machine-learning technology to give healthcare organizations, regulators, and insurers the real-time, actionable insights they need to have a direct and dramatic impact on patient experiences.
Visit website
Download documents
Osteoweld
Redefining fracture fixation with ultrasonic welding system

OSTEOWELD introduces an ultrasonic welding system for bone fractures. Unlike traditional methods with limited fixation options, OSTEOWELD welds polymer-based screws directly to bone or metal implants using high-frequency vibrations. This innovative approach offers more versatility, shorter procedure times, and reduced radiation exposure, making it ideal for complex fractures, especially around joints.

Active
🇬🇧 United Kingdom
Osteoweld
FlowView Diagnostics
Accurate and fast monitoring of leukemia patients

FlowView Diagnostics addresses the challenge of analyzing complex cell data from blood samples using multiparameter flow cytometry, vital for conditions like leukemia monitoring. They tackle this with an algorithm that quickly processes raw data, detecting Minimal Residual Disease (MRD) more accurately and rapidly than manual methods. In a case study, the algorithm analyzed 8 million cells in 2 minutes, presenting simplified results for quicker interpretation, reducing the risk of false negatives, and enhancing efficiency in leukemia monitoring.

Active
🇳🇱 Netherlands
FlowView Diagnostics
Artifex
Off the shelf vascular graft alternative

ArtiFex tackles a solution for coronary and peripheral bypass surgeries. Traditional grafts from the great saphenous vein face issues like rapid degeneration, leading to complications. With millions of bypass surgeries conducted annually and a billion-dollar market for vascular grafts, there's a clear need for improvement. ArtiFex's innovative vascular graft, made of cobalt-chrome and cellulose promotes tissue regeneration, strength, and ensures blood flow without causing clotting or immune reactions.

Active
🇦🇹 Austria
Artifex
Liftya
Unique personalized shoulder assisting device

Introducing Liftya, a solution for shoulder instability. Developed with a patented spherical hinge mechanism, Liftya mimics the natural shoulder joint movement, offering stability and full range of motion. Unlike traditional braces, Liftya promotes motor recovery and independence, reducing pain and healthcare costs for patients.

Active
🇩🇰 Denmark
Liftya
Retinacheck
Using retinal images for diabetic retinopathy

Retinacheck addresses the challenge of Diabetic Retinopathy, the leading cause of blindness in working-age adults, particularly in regions with poor access to eye care. With over 23% of China's 110 million diabetics affected, Retinacheck's solution becomes crucial. By utilizing retinal images captured by a fundus camera, their Convolutional Neural Network algorithm can diagnose Diabetic Retinopathy with over 94% accuracy, surpassing traditional methods.

Exited
🇳🇱 Netherlands
Retinacheck
Larynxlock
Solution to prevent laryngeal air leaks during surgery

Introducing LarynxLock, prevents air leaks during surgery with a gentle pressure on the mouth's base, ensuring patients receive uninterrupted air supply. LarynxLock not only safeguards patients from complications but also reduces physical strain and surgery duration, offering a smart and cost-effective solution for improved surgical outcomes.

Active
🇳🇱 Netherlands
Larynxlock
Axial
Bone repair system reduces pain after surgery and brings better recovery

Axial Orthopaedics Inc. revolutionizes trauma treatment with their innovative intramedullary nailing system. Current systems often lead to bone misalignment and joint pain, blocking post-procedural recovery. Axial Orthopaedics's modular system offers greater flexibility in bone alignment and healing. This system not only addresses postoperative pain but also reduces complications. Its intra-operative modularity and rotational capabilities allow surgeons to achieve better fracture fixation and improved outcomes, filling a crucial gap in current technology.

Active
🇺🇸 United States of America
Axial
Biteon
Bringing personalized care to dental implants

BiteOn has devised a breakthrough in dental implants: personalized implants tailored to each patient's jawbone structure. Traditional bone graft procedures are costly and painful, often extending treatment time by six months. BiteOn's solution eliminates the need for bone grafts by designing implants based on 3D scans of the patient's mouth. This innovation promises quicker, less painful, and more successful dental replacements, offering hope to patients previously unable to undergo traditional procedures.

Active
🇳🇱 Netherlands
Biteon

Our impact

14
Countries active in
20-25
Ventures built annually
247K
Patients impacted
70+
Active ventures in our portfolio
80+
Healthcare experts
€135M+
Raised by NLC ventures

Explore our 2023 Impact report

Woman with hands in the air in nature
Maurits Schouten
I consider the medical sector to be very attractive. However, without the right expertise, network, and diversification, the risks can be significant. NLC removes these barriers and creates an attractive opportunity for me to participate as an investor in this sector.
Maurits Schouten

Maurits Schouten

Impact investor and Board Member of PYM

Peter Veldman
What I really like about NLC and what triggered my investment in the company is the strong culture and the quality of the team. NLC is able to de-risk the innovation cycle by building ventures at scale, thereby playing a leading role in shaping the future of healthcare.
Peter Veldman

Peter Veldman

Advisor and previous Deputy Head of Fund Operations at EQT Group

Invest in a portfolio of companies

A formal clothed man on a bridge in the city

Create a healthier future with us

Nina Rijnders
Investor Relations